Clinical Trial Update: NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating NAD+ precursor NMN in combination with radioimmunotherapy for advanced non-small cell lung cancer. The study status indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nicotinamide Mononucleotide (NMN) (nicotinamide mononucleotide)

Snippet

Sponsor: Sichuan University | Conditions: Solid Tumor, Non Small Cell Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING